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ABSTRACT 
The current review aimed to synthesize the literature on the complex relationship between food consumption and nutritional status as 
well as the digestive system in order to examine the relationship between immunity and potential responses to COVID-19 infection. 
The goal is to help inform the many healthcare professionals working with COVID-19 patients. A literature search was performed on 
PubMed, Scopus, and EMBASE databases. Hand searches were also undertaken using Google and reference lists to identify recent 
evidence. Studies were critically appraised, and the findings were analyzed by narrative synthesis. Nutritional status can impact 
immunity in several ways, including affecting susceptibility to infection, severity of disease, and recovery time, and is therefore a 
significant consideration in the management of COVID-19. COVID-19 can also impact digestive function, which can further impact 
nutritional status. The role of Vitamin D deficiency in vulnerability to severe respiratory infections, including COVID-19, has been 
recognized, and it may have a role in treatment where deficiency is indicated. Healthcare professionals should be aware that obesity 
may be accompanied by micronutrient malnutrition including vitamin D deficiency and alterations in the microbiome and 
inflammatory responses, which can further impact immunity and disease severity. Multidisciplinary team-work is recommended in 
the management of patients with COVID-19, and approaches should include a consideration of nutritional status (both macronutrients 
and micronutrients), body weight, and gastrointestinal signs and symptom. 
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Introduction  
  1 The COVID-19 pandemic is a novel infection and a 
major global healthcare challenge which highlights the 
need for cost-effective strategies that both prevent 
complications and support recovery, reducing recovery 
times and complications wherever possible. The current 
review aims to consider the relationship between 
COVID-19 infection and nutritional status, including 
obesity, and the broader impact it may have on both 
digestive function and gastrointestinal (GI) symptoms 
of COVID-19 infection. It is hoped this will inform all 
areas of healthcare practice and increase awareness of 
the importance of considering nutrition in a 
multidisciplinary approach.   
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Method and Approach 
A narrative approach has been used to synthesize 
findings from a literature search using search terms 
such as COVID-19 and nutritional status, obesity, 
malnutrition, nutritional deficiency, vitamin D, and 
microbiome. PubMed, Scopus and EMBASE databases 
were used and hand searches were also undertaken 
using Google and reference lists to identify recent 
evidence. Studies were critically appraised, and the 
findings were analyzed by narrative synthesis. 
Malnutrition 
The nutritional status of populations is recognized as a 
key factor influencing resilience against destabilization 
in the current COVID-19 pandemic (1). Community 
resilience is generally considered to be the ability to 
recover from adverse events (2). Malnutrition is an 
established risk factor for lowered immunity (3), and a 
hospital stay can increase a patient’s chances of both 
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complications and re-admission after discharge (4). 
Malnutrition can occur in both energy and 
macronutrient terms (carbohydrates, proteins, fats) and 
may also occur as micronutrient (vitamins and 
minerals) deficiency, which can potentially co-exist 
with obesity, where someone is potentially overfed in 
terms of energy (Kcal) but deficient in one or more 
micronutrients. A study published in 2017 reported on 
data from 1990-2017 and concluded that dietary factors 
were linked to 11 million deaths and 255 million 
disability-adjusted life-years across the world in 2017 
(5). 
Any infection outcome is affected by nutritional status, 
due to effects on both innate and adaptive immune 
responses (6). Vitamins B, C, and E alongside iron, 
selenium, and zinc play a supporting role in 
immunocompetence (7, 8), and any chronic shortages 
in these micronutrients may further impair immune 
function through cell activation and changes in 
signaling, molecule production, and gene expression 
(9). It should also be remembered that diet (and 
particularly components such as fiber) influences gut 
microbial composition which helps to promote immune 
responses in the body (10).  
Vitamin D Status 
Vitamin D may protect against the risk of contracting 
influenza (11), and vitamin D deficiency is associated 
with a higher risk of community-acquired pneumonia 
(12) and GI disorders such as inflammatory bowel 
disease (13). It also seems to be an important factor in 
other viral respiratory infections. Alipio (14) presented 
significant data (p<0.001) regarding vitamin D status 
and the severity of SARS symptoms observed in 
patients admitted to three hospitals in South Asia. The 
data indicated that the majority of patients with mild 
symptoms (n=85.5%) presented with serum OH(D) of 
31.2 ng/mmol (normal vitamin D status), with only 
3.6% of patients in this category presenting with severe 
and critical symptoms (14).  
Vitamin D deficiency is common in people who are 
housebound and not going outside as vitamin D is 
synthesized through skin exposure to sunlight. Thus, a 
population in quarantine or lockdown may experience 
lowered levels of vitamin D. Moreover, skin 
pigmentation also affects production levels; skin with 
more pigmentation will produce less, so deficiency is 
more common in people with darker skin (15). Debates 
about whether this is implicated in higher death rates 
from COVID-19 infection among Black, Asian, and 
minority ethnic people (16) are gaining momentum. 
Both obesity and Type 2 diabetes (T2D) are also 
associated with high rates of vitamin D deficiency (17). 
It is also known that people with diabetes and obesity 
are more vulnerable to severe disease with COVID-19 
infection. It seems vitamin D deficiency is relatively 
commonplace, as over a billion people globally are 
thought to be affected (18). In the UK, a country with 
high COVID-19 death rates, around a third of adults 
appear to be deficient in vitamin D. The National Diet 
and Nutrition Survey analysis of the last 9 years 
reported that in the UK from January to March, 19% of 
children aged 4 to 10 years, 37% of children aged 11 to 
18 years, and 29% of adults had low Vitamin D levels 
(25-OHD below 25nmol/L), indicating a risk of 
deficiency (19). 
Stress 
Physical trauma is known to cause injury and 
dysfunction of the gut as well as increased intestinal 
permeability (20). Psychological stress also impacts gut 
dysbiosis and permeability by increasing the 
corticotropin-releasing hormone and its effect on TNFα 
(21), as well as other pro-inflammatory cytokines, 
which is evident in viral infections. The effect of being 
critically ill may compound an already compromised 
GI tract, and it is known that gut dysfunction can 
contribute to multi-organ dysfunction syndrome (20). 
Other GI mechanisms relevant to the pathophysiology 
of viral infection include the reduction of butyrate, 
which helps to maintain the gut barrier and is known 
for its anti-inflammatory effects, and the elevation of 
circulating lipopolysaccharides from the increase in gut 
permeability (22). This leads to the upregulation of 
inflammatory cytokines, which triggers systemic 
inflammation (23, 24). The consequential impact on 
mitochondrial function together with immune system 
responses further demonstrate the potential effects of 
COVID-19 on a range of interconnected body systems 
(25). 
Microbiome and Immunity 
Gut microbiota influences the maturation and 
development of immune cells such as dendritic cells 
and T cells, while also regulating the synthesis of the 
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cytokines IL-10 (suppresses Th-1 dominant pro-
inflammatory response) and TGF-ß (promotes the 
development of regulatory T cells) (26). Gut microbiota 
can also have indirect modulatory effects on 
inflammation including the production of short chain 
fatty acids (SCFA) (27) and the promotion of the 
synthesis of antimicrobial peptides (28). Thus, the 
interaction between the host’s microbiome and the 
immune system is complex due to the many pathways 
by which the microbiota can modulate immune 
responses to pathogens.  
Lactobacillus species specifically have been recognized 
for their role in stimulating the innate immune response 
by acting as ligands for Toll-like receptors (TLR) and 
activating important signaling pathways such as NF-kß, 
mitogen-activated protein kinase, and peroxisome 
proliferator-activated receptor gamma, all of which are 
involved in regulating cellular behaviors such as 
inflammatory responses (29). Furthermore, other 
species have been found to produce substances which 
can cross epithelial cell membranes and bind to 
intracellular receptors known as nucleotide-binding 
oligomerization domain receptors (NLRs) (30). NLR 
activation is responsible for regulating inflammatory 
responses by acting on the NF-kß and peroxisome 
proliferator-activated receptor gamma signaling 
pathways. TLRs and NLRs are associated with 
activating caspase 1, an enzyme involved in the 
maturation of the pro-inflammatory cytokines IL-1ß 
and IL-18 (31). Such pro-inflammatory effects have 
been suggested to serve physiological benefits such as 
immune system response ‘priming’, which can promote 
the host’s defense against pathogens (29). 
Decreased microbiome biodiversity resulting from the 
lack of exposure to microorganisms due to excessive 
cleanliness (the ‘Hygiene Hypothesis’) (32), increased 
antibiotic use, and poor diet have been suggested to be 
major contributing factors in the increasing levels of 
inflammatory disorders. An imbalance in gut flora can 
trigger an inflammatory immune response, causing 
intestinal hyperpermeability, which in turn can trigger a 
further localized inflammatory response within the gut 
(33), creating a vicious cycle of inflammatory 
responses. SARS-Cov-2 causes lung infections by 
binding to angiotensin-converting enzyme 2 (ACE2) 
receptors within alveolar epithelial cells which, 
interestingly, are also expressed within intestinal 
enterocytes. Furthermore, SARS-Cov2 RNA was 
reported to be found in the feces of infected individuals 
(34). These factors along with the fact that microbiome 
diversity is reduced in older age, and it is the elderly 
patients who have suffered fatally from COVID-19, 
clearly indicates a possible link between COVID-19 
immune response and gut microbiome. 
COVID-19 GI Symptoms 
Evidence suggests GI symptoms including nausea, loss 
of appetite, diarrhea and vomiting, and abdominal pain 
have been adduced in approximately a third of COVID-
19 patients (35-38). More recently, olfactory and 
gustatory dysfunction have been reported as common 
symptoms, which may affect appetite (90). 
How the virus enters the cell 
Entry of the coronavirus into the cytoplasm of the host 
cell is initiated by the attachment of the receptor 
binding domain of the viral glycoprotein known as the 
spike (S) protein to the membrane protein ACE2. 
Transmembrane serine protease (TMPRSS) 2 facilitates 
entry into the cell by cleaving the S protein. As 
previously mentioned, ACE2 expression has been 
detected on the enterocytes of the small intestine, more 
so on the crypt epithelium and less so on the surface 
epithelium of the colon (34). TMPRSS2 has been 
observed on surface and crypt epithelia in the colon but 
is less obvious in the ileum and only on the crypt 
epithelium (39). 
Obesity 
Obesity, classified as a body mass index (BMI) > 
30kg/m2, is recognized as one of the most significant 
public health problems in the world with approximately 
two billion overweight men and women (39% of adults 
aged 18 and over), of which 650 million are obese (40). 
If current trends of prevalence continue, 2.7 billion 
adults will be overweight by 2025, and one billion of 
these will be obese (40). One possible explanation of 
the virulence factor for COVID-19 in obesity and 
adverse outcomes is the rising issue of micronutrient 
and protein deficiency resulting from a monotonous 
diet often seen in a medical condition known as 
sarcopenic obesity, where low muscle mass and obesity 
coexist (41). Not only is there an increase in low-grade 
systemic inflammation due to excess adipose tissue, but 
the direct effect of vitamin deficiency such as A and D 
can lead to compromised functioning of antibody-
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secreting cells (42) and T-cell proliferation (43), 
respectively. 
Obesity as a Risk Factor for Severe 
Disease in COVID-19 
Obesity has been identified by the World Health 
Organization as a serious risk factor for COVID-19 
outcomes and for poor adverse outcomes for COVID-
19 (44). Increasing risks have been associated with 
increasing BMI (45). In a New York hospital cohort 
study (n=3615), obesity was cited as a risk factor for 
treatment escalation (46) and for admission to intensive 
care units (ICU) in the United Kingdom (UK). A study 
by the UK Intensive Care National Audit and Research 
Centre reported that over 73% of those in ICUs were 
overweight or obese (34.6% and 38.5%, respectively) 
(47). Obesity was recognized as a risk factor for in-
hospital mortality after adjusting for other 
comorbidities in an observational, prospective cohort 
study in the UK (n=16,749) (48).  
Although obesity is associated with severe forms of 
COVID-19, the prevalence of severe obesity (BMI 
>35kg/m2) reported in ICUs may reflect the local 
prevalence of obesity as seen in two seminal studies in 
France, one in Lille, where the local prevalence was 
reported as 28.2% (45), and one in Lyon, where the 
prevalence was 11.3%. The requirement for invasive 
mechanical ventilation (IMV) compared to lean 
subjects reflected these differences with 68.6% and 
58.4%, respectively. In a retrospective cohort study, 
obesity prevalence was high among ICU patients (44), 
and in other research, patients with a BMI between 30-
34.9kg/m2 were 1.8 times more likely than those with a 
BMI <30kg/m2 to be admitted to the ICU (46). This is 
more of an issue in the USA and UK (countries which 
have high mortality rates in the current pandemic) 
because of the high prevalence of obesity (42% and 
29%, respectively) (49, 50) 
Obesity is a risk factor for impaired metabolic function, 
such as insulin resistance and T2D (51). The metabolic 
effect of excessive fat may result in reduced pancreatic 
beta cell performance, which may be compounded by 
the direct effect of COVID-19 on function (52). 
Inflammation of adipose tissue results in other 
metabolic dysfunctions such as dyslipidemia, 
hypertension, and cardiovascular disease (CVD) (51, 
53). Although comorbidities for obesity such as heart 
and lung disease, hypertension, and T2D may confound 
results, severe obesity has been associated with ICU 
admissions and obesity associated with the use of IMV 
(both reaching statistical significance) (54). 
Obesity and Immune Function 
Obesity may predispose adults to impaired immune 
function and increased susceptibility to infection (51). 
Multiple factors are implicated, such as chronic 
inflammatory status, delayed immune response, and the 
complex relationships and interactions between adipose 
tissue and the immune system (55). High levels of 
ACE2-expressing cells are found in adipose tissue, and 
because obese individuals have more adipose tissue, 
this could elucidate that they have a greater amount of 
ACE2. COVID-19 has an enhanced affinity for ACE2 
(53), which is a supposed receptor for the entry of 
COVID-19 into host cells (56).  
Adipose tissue may contribute to the progression of 
COVID-19 by other mechanisms, including the 
imbalance between anti-and pro-inflammatory 
cytokines, particularly adipokines; overexpression of 
the latter may lead to aberrant chemotaxis and 
abnormal macrophage differentiation, further 
compromising immune function (55). Other innate 
responses associated with obesity lead to the excessive 
release of pro-inflammatory cytokines such as IL-6 
(55), TNFα, IFNý, and IL-2 and higher levels of 
circulating C-reactive protein (53). Elevated IL-6 levels 
have been correlated with ICU admission, respiratory 
failure, and adverse outcomes (39). 
Obesity and the Microbiota 
Studies have shown that obesity is associated with 
changes in the assortment of microorganisms inhabiting 
the GI tract, which include viral, fungal, bacterial, and 
single-celled microorganisms called arcaea, collectively 
known as the gut microbiota, and that obese adults have 
less diversity and richness in the bacterial composition 
(57-59). As previously mentioned, gut bacteria play a 
vital role in protection against pathogenic 
microorganisms, immune modulation, and other 
functions such as digestion and metabolism and SCFA 
production (60-62). 
Firmicutes and Bacteroidetes make up approximately 
90% of the total microorganisms with some research 
reporting an increased ratio of Firmicutes to 
Bacteroidetes in the feces of obese subjects (57, 63, 
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64); however, a systematic review was equivocal in its 
overview of the association between BMI and 
microbiota (65) with some studies supporting this 
theory and others finding no association, although this 
may be explained by differing methodological 
approaches.  
Recent evidence suggests the presence of 
microorganisms such as Bacteroidetes, Firmicutes, and 
Proteobacteria in the lungs and that a bidirectional 
relationship exists between the lungs and the gut (66). 
Dysbiosis, which results from a lack of gut diversity, 
has been associated with many diseases, including 
acute respiratory distress syndrome and sepsis (67). 
2.4. Obesity and Dietary Habits 
Obesity is affected by unhealthy eating habits, as seen 
in a cross-sectional study (n=1557) that looked at the 
association of abdominal obesity with food inadequacy 
and physical activity (68). They reported a lower 
likelihood of abdominal adiposity in those who 
consumed a minimum of three portions of fruit a day 
and did not exceed the upper limit of saturated fat (35% 
and 28%, respectively). Furthermore, in data from a 
longitudinal study n=50, improvements were found in 
weight, body fat, and waist circumference on a diet of 
fruits, vegetables, and grains containing 30g fiber/day 
compared to controls (69). Normal weight adults 
(n=52) consumed 43% more complex carbohydrates 
and 33% more fiber than overweight/obese adults when 
matched for gender, age, and physical activity (77).  
Diets that include high fat and low fiber can impact the 
diversity of the human gut microbiota, even over a few 
days (70). Conversely, a fiber-rich diet may have a 
positive effect on the gut microbiota and improve both 
metabolic and immune markers; for example, non-
digestible carbohydrates such as whole grains may 
reduce pro-inflammatory cytokine IL-6 and insulin 
resistance (71). Interestingly, switching from a Western 
style diet of high fat/high sugar refined carbohydrates 
to a low-fat diet rich in plant-polysaccharides may 
influence the composition of microbiota, once again 
within a relatively short time, this time to the benefit of 
the microbiota (42). In addition, probiotics found in 
fermented foods may further reduce inflammation and 
help to regulate innate immunity (72). Anti-
inflammatory marker IL-10 may be increased through 
the intake of prebiotics, increasing the production of 
SCFAs and improving the health of the GI-associated 
lymphoid tissue. Not only gut microbiota, but also lung 
microbiota is improved, thus offering a potential 
strategy for improving clinical outcomes of COVID-19 
(41).  
Melatonin 
Melatonin, released by the pineal gland at nighttime, 
has long been associated with the adjustment of the 
circadian phase to the environment, known as circadian 
rhythm entrainment; however, it also has antioxidant 
and anti-inflammatory properties, the latter due to its 
close relationship with mitochondrial function (73). 
The melatonergic pathway, which starts with the 
conversion of tryptophan to serotonin, then to N-
acetylserotonin, and finally to melatonin, has created 
some interest due to its interaction with COVID-19 and 
other viruses (25). Elevated levels of stress may affect 
the availability of tryptophan for the melatonergic 
pathway, thus causing circadian (74, 75) and 
mitochondrial dysregulation (76). Pre-existing medical 
conditions mentioned previously have been linked to 
both of these regulatory mechanisms as well as to gut 
dysbiosis and increased gut permeability. 
Supportive Nutritional Interventions 
Multidisciplinary Team Practice 
This review has indicated clear links between nutrition 
status (specifically micronutrient insufficiency and 
deficiency), compromised gut function, and the effects 
of obesity on viral severity, including SARS, CAP, and 
now COVID-19. Hence, a multidisciplinary approach is 
likely to be of benefit in terms of patient outcomes.  
Health services should adapt to prioritize reducing 
obesity and weight loss in general, given the inverse 
correlation between obesity/excess weight and COVID-
19 severity. In response to this, the UK government 
launched an obesity strategy, labeled the COVID-19 
‘wake-up-call’, in July 2020 (81). The preventative 
strategies outlined include general practitioners being 
incentivized to prescribe activity and exercise to 
enhance physical fitness and primary care healthcare 
staff being trained as ‘healthy weight coaches’ to 
provide more specialist support to those in need (81).   
Allied health professionals with nutrition expertise such 
as dieticians, nutritionists, and nutritional therapists 
may also have a role in supporting individuals in their 
recovery from COVID-19 or in advising those seeking 
preventative or ‘prehabilitation’ healthy eating advice 
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or supplement regimes (85). They can also help support 
individuals with weight loss. Ostensibly, these nutrition 
professionals will be required to assess the nutritional 
status and check drug-nutrient interactions of 
individuals in the first instance, before they provide 
safe guidance on nutritional supplementation. Since the 
start of the pandemic, claims, often unfounded and 
unsafe, of how specific foods and herbs may provide 
protection from COVID-19 have been circulating via 
social media (1). Thus, nutrition professionals have the 
added responsibility of dispelling any myths spread 
during the pandemic and ensuring safe intake of 
immune supporting nutrients (1).   
Nutritional supplementation as Adjunct Treatment in 
COVID-19 
In supporting patients with COVID -19, vitamin D has 
the potential to be used as an adjunct treatment to 
medication. A variety of doses have been used to treat 
SARS and CAP to date, with therapeutic applications 
varying from 30-2500 μg/d (77, 78). Indeed, the results 
of a study currently ongoing at University Hospital, 
Angers (France), with COVID-19 patients ≥70 years of 
age are awaited. The hypothesis seeks to prove that 
high dose (2 x 2000,000 IU/d or 2 x 5 mg/d) vitamin D 
is more effective on improved prognosis when 
compared to a standard dose (50,000IU/d or 125 μg/d). 
Evidence also exists in support of the probiotic 
Lactobacillus Rhamanous, which can be given as an 
oral supplement, and its efficacy in helping patients 
avoid being ventilated as well as in treating viral 
respiratory infection. Bifidobacterium appears to 
improve immune function and intestinal microbiota 
(79, 80). Both strains support further consideration for 
adjunct treatments in addressing possible dysbiosis and 
improving microbiome diversity.Vitamin C is known to 
be immunomodulatory. Moreover, antimicrobial and 
high-dose intravenous vitamin C is being researched for 
its potential in blocking the cytokine storm associated 
with COVID-19 infection (91).  
Preventative Nutritional Intake and Supplementation 
for the General Population 
The debate regarding standardized, population-wide 
supplementation is ongoing, and the COVID-19 
pandemic has certainly raised more questions around 
this topic. For example, the current UK 
recommendations for vitamin D supplementation of 10 
μg/d are based on the role of vitamin D in bone health 
and calcium metabolism and do not take into account 
its role in immune regulation (82). Furthermore, this 
recommendation is for everyone aged 1 and older (8.5 
μg/d birth to 1 year), with supplementation 
recommended in the winter months when sunlight is 
reduced. While not discounting the potential risks 
associated with higher intakes of vitamin D (83), this 
review has presented evidence linking the impact of 
modern day life, e.g., poor eating habits, stress, lack of 
microbiome diversity, and being overweight or obese, 
to nutritional insufficiency.     
Indeed, it is apparent that levels of micronutrient intake 
above those set by public health bodies (such as the 
RDA in the USA or the RNI in the UK) are required to 
support optimal function of the immune system, with 
recommendations for supplementation of vitamin D to 
be above the RDA (84). Similarly, this implication can 
be made to vitamin C, with the current UK RNI for 
adults being 40 mg/day (set at a level to prevent 
deficiency in the majority 97.5% of the population) 
(86). Vitamin C deficiency is linked to severe 
respiratory tract infections and overall disease severity, 
and plasma levels are known to be affected by infection 
 
Table 1.  Recommended intakes of vitamins D and C to support optimal immunity for the wider population. 
Nutrient Justification Recommendation 
Vitamin D Revision of the current UK guidelines is advocated (82). 
10 μg/d is not sufficient for individuals in at-risk groups at 
any time (82). 
10 μg/d is not sufficient for individuals between October-
April in cold, Northern Hemisphere countries (77). 
 
Daily intake of 50 μg/d (84, 85) 
 
 
[Daily intake of 50-125 μg/d has been advised 
dependent on age, risk, and time of year (11).] 
Vitamin C 40 mg/d is not sufficient for UK adults (86). 
EU guidance for adults is 95 mg/d (87). 
Higher daily doses (≥200mg/d) are required for optimal 
immune function (84). 
Daily intake of 200 mg/d (84) 
[Daily intake of 1-2 g/d for individuals who are unwell 
(84)] 
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(84). The UK RNI is significantly less than guidance in 
other countries, and new evidence is emerging to 
optimally support immune function (84, 87). Table 1 
outlines a summary of the recommendations for 
supplementation of vitamins D and C based on current 
evidence. 
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